Computational study of molecular electrostatic potential, docking and dynamics simulations of gallic acid derivatives as ABL inhibitors
暂无分享,去创建一个
D. R. Sherin | T. K. Manojkumar | P. S. Arun | K. R. Raghi | M. J. Saumya | V. N. Sobha | D. Sherin | T. Manojkumar | V. Sobha | P. Arun | M. Saumya
[1] S. Gunasekaran,et al. Vibrational and electronic investigations, thermodynamic parameters, HOMO and LUMO analysis on Lornoxicam by density functional theory , 2015 .
[2] R. Agarwal,et al. Gallic Acid, an Active Constituent of Grape Seed Extract, Exhibits Anti-proliferative, Pro-apoptotic and Anti-tumorigenic Effects Against Prostate Carcinoma Xenograft Growth in Nude Mice , 2009, Pharmaceutical Research.
[3] P. Guiraud,et al. Study of antimutagenic and antioxidant activities of gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus. Confirmation by microarray expression profiling. , 2007, Chemico-biological interactions.
[4] W. Sherman,et al. Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. , 2010, Journal of chemical theory and computation.
[5] Daniela Cilloni,et al. Molecular Pathways: BCR-ABL , 2011, Clinical Cancer Research.
[6] H. Salem,et al. Gallic Acid: A Promising Lead Molecule for Drug Development , 2016 .
[7] M. Karabacak,et al. Vibrational spectroscopic studies, NLO, HOMO-LUMO and electronic structure calculations of α,α,α-trichlorotoluene using HF and DFT. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[8] M. Pradeepa,et al. AN IN-SILICO APPROACH FOR THE IDENTIFICATION OF ANTI-COLON CANCER PHYTOCOMPOUNDS FROM AVENA SATIVA.L , 2014 .
[9] J. Melo,et al. The molecular biology of chronic myeloid leukemia. , 2000, Blood.
[10] P. Varadwaj,et al. Identification of Dual Natural Inhibitors for Chronic Myeloid Leukemia by Virtual Screening, Molecular Dynamics Simulation and ADMET Analysis , 2015, Interdisciplinary Sciences: Computational Life Sciences.
[11] M. Chopp,et al. Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. , 2010, European journal of pharmacology.
[12] K. Bothara,et al. Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives. , 2008, Bioorganic & medicinal chemistry.
[13] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[14] A. Mishra,et al. Gallic acid: molecular rival of cancer. , 2013, Environmental toxicology and pharmacology.
[15] R. Patch,et al. 2-Hydroxy-4,6-diamino-[1,3,5]triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors. , 2005, Journal of medicinal chemistry.
[16] R. Dua,et al. Pharmacological Significance of Synthetic Heterocycles Scaffold: A Review , 2011 .
[17] Kenneth D. Jordan,et al. Comparison of Density Functional and MP2 Calculations on the Water Monomer and Dimer , 1994 .
[18] Z. Xin,et al. Powerful protective effects of gallic acid and tea polyphenols on human hepatocytes injury induced by hydrogen peroxide or carbon tetrachloride in vitro , 2010 .
[19] S. Sankar,et al. Molecular Docking studies and in-silico ADMET Screening of Some novel Oxazine substituted 9-Anilinoacridines as Topoisomerase II Inhibitors , 2017 .
[20] W. Sherman,et al. Probing the α‐Helical Structural Stability of Stapled p53 Peptides: Molecular Dynamics Simulations and Analysis , 2010, Chemical biology & drug design.
[21] Om Prakash Sharma,et al. Identification of novel tyrosine kinase inhibitors for drug resistant T315I mutant BCR-ABL: a virtual screening and molecular dynamics simulations study , 2014, Scientific Reports.
[22] Mohammed Afzal Azam,et al. Extra precision docking, free energy calculation and molecular dynamics studies on glutamic acid derivatives as MurD inhibitors , 2017, Comput. Biol. Chem..
[23] David R. Kaplan,et al. Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.
[24] K. Selvaraj,et al. biological Aspects of 1,3,4 -oxadiazole derivatives , 2014 .
[25] Surya Pratap Singh,et al. Discovery of potential inhibitor against human acetylcholinesterase: a molecular docking and molecular dynamics investigation , 2017, Comput. Biol. Chem..
[26] Rong Zhang,et al. Computational analysis of binding between benzamide-based derivatives and Abl wt and T315I mutant kinases , 2016 .
[27] G. Marfé,et al. Cancer Stem Cells in Chronic Myelogenous Leukemia , 2014 .
[28] M. Mann,et al. Phosphotyrosine interactome of the ErbB-receptor kinase family , 2005, Molecular systems biology.
[29] G. Bolwell,et al. Phenols in the plant and in man. The potential for possible nutritional enhancement of the diet by modifying the phenols content or profile , 2000 .
[30] K. Bothara,et al. Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies. , 2010, Bioorganic & medicinal chemistry.
[31] C. Remya,et al. Rational design and interaction studies of combilexins towards duplex DNA. , 2016, Molecular bioSystems.
[32] C. Jun,et al. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[33] Chi V Dang,et al. MYC on the Path to Cancer , 2012, Cell.
[34] Maurizio Fermeglia,et al. Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations. , 2005, Bioorganic & medicinal chemistry.
[35] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[36] E. Reddy,et al. Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. , 2010, Genes & cancer.
[37] J. Melo,et al. Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation. , 2004, Hematology/oncology clinics of North America.
[38] Shabbir Ahmad,et al. DFT/TD-DFT calculations, spectroscopic characterizations (FTIR, NMR, UV-vis), molecular docking and enzyme inhibition study of 7-benzoyloxycoumarin , 2018, Comput. Biol. Chem..